Validation of a flow cytometric acridine orange micronuclei methodology in rats.
暂无分享,去创建一个
P Juneau | D Zielinski | G. Krishna | M. Bleavins | S. Bulera | P. Juneau | K A Criswell | G Krishna | G A Urda | S Bulera | M R Bleavins | D. Zielinski | G. Urda | K. Criswell
[1] J. T. Macgregor,et al. Strategies and testing methods for identifying mutagenic risks. , 2000, Mutation research.
[2] R R Tice,et al. In vivo rodent erythrocyte micronucleus assay. , 1994, Mutation research.
[3] W. R. Bruce,et al. Comparison of the effects of 1,2-dimethylhydrazine and cyclophosphamide on micronucleus incidence in bone marrow and colon. , 1983, Mutation research.
[4] G. Choudhary,et al. Human health perspective on environmental exposure to hydrazines: a review. , 1998, Chemosphere.
[5] Y. Ikeda,et al. Reticulocyte maturity as an indicator for estimating qualitative abnormality of erythropoiesis. , 1994, Journal of clinical pathology.
[6] G Aubel-Sadron,et al. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review. , 1984, Biochimie.
[7] L. Abramsson-Zetterberg,et al. The micronucleus test in rat erythrocytes from bone marrow, spleen and peripheral blood: the response to low doses of ionizing radiation, cyclophosphamide and vincristine determined by flow cytometry. , 1999, Mutation research.
[8] G. Krishna,et al. Practical aspects of mutagenicity testing strategy: an industrial perspective. , 2000, Mutation research.
[9] M. Weinblatt,et al. Methotrexate: mechanism of action, pharmacokinetics, clinical indications, and toxicity , 1991, Current opinion in rheumatology.
[10] J. T. Macgregor,et al. The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program. , 1983, Mutation research.
[11] N. Lawrence,et al. Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle , 1998, Medicinal research reviews.
[12] F. Lacombe,et al. High fluorescence reticulocytes are an indicator of bone marrow recovery after chemotherapy , 1995, European journal of haematology.
[13] E Mirkova,et al. Species-specific response to the rodent carcinogens 1,2-dimethylhydrazine and 1,2-dibromo-3-chloropropane in rodent bone-marrow micronucleus assays. , 1988, Mutagenesis.
[14] S. Dertinger,et al. Malaria-infected erythrocytes serve as biological standards to ensure reliable and consistent scoring of micronucleated erythrocytes by flow cytometry. , 2000, Mutation research.
[15] G. Krishna,et al. Principles and practices of integrating genotoxicity evaluation into routine toxicology studies: A pharmaceutical industry perspective , 1998, Environmental and molecular mutagenesis.
[16] W Schmid,et al. The micronucleus test. , 1975, Mutation research.
[17] S. Rodenhuis,et al. The clinical pharmacology of alkylating agents in high-dose chemotherapy. , 2000, Anti-cancer drugs.
[18] D. Niethammer,et al. Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). , 1998, International journal of molecular medicine.
[19] J. T. Macgregor,et al. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring , 2000, Environmental and molecular mutagenesis.
[20] M C Cimino,et al. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. , 1990, Mutation research.
[21] G. Krishna,et al. Use of acridine orange in: flow cytometric evaluation of erythropoietic cytotoxicity. , 1998, Mutation research.
[22] M. Hayashi,et al. In vivo rodent micronucleus assay: protocol, conduct and data interpretation. , 2000, Mutation research.
[23] B. Margolin,et al. Guidelines for the conduct of micronucleus assays in mammalian bone marrow erythrocytes. , 1987, Mutation research.